Clinical Trial Agreement Negotiation – Everything Your Lawyers Want You to Know – Part I

January 15, 2025—In this, three-part series of live webinars we will provide an opportunity for attendees to hear from clinical trial attorneys as they share the critical pieces of a clinical trial agreement and how to mitigate risk. Attendees will gain a better understanding of the requirements of both sponsors and sites and participate in a discussion about how to meet the needs of all parties in the contract.

Clinical Trial Agreement Negotiation – Everything Your Lawyers Want You to Know – Part II

January 22, 2025—In this, three-part series of live webinars we will provide an opportunity for attendees to hear from clinical trial attorneys as they share the critical pieces of a clinical trial agreement and how to mitigate risk. Attendees will gain a better understanding of the requirements of both sponsors and sites and participate in a discussion about how to meet the needs of all parties in the contract.

Clinical Trial Agreement Negotiation – Everything Your Lawyers Want You to Know – Part III

January 29, 2025—In this, three-part series of live webinars we will provide an opportunity for attendees to hear from clinical trial attorneys as they share the critical pieces of a clinical trial agreement and how to mitigate risk. Attendees will gain a better understanding of the requirements of both sponsors and sites and participate in a discussion about how to meet the needs of all parties in the contract.

Action Steps for FDA Diversity Action Plans

In this webinar, industry experts offered examples of how diversity action plans vary among therapeutic areas — and why one size does not fit all. They also explained why it’s important to incorporate action plans earlier in the clinical trial process, as well as consequences for failing to follow a submitted plan.

From Conflict to Collaboration: Enhancing Site and Sponsor/CRO Relationships

This webinar explored the perspectives and occasional conflicting interests of both parties, fostering mutual understanding. Representatives from each organization shared insights, real-life examples, and practical tools to overcome challenges, promoted productive collaboration, and contributed to clinical trial success